Congress
Program - Wednesday, June 6
|
|
|
|
08:15 - 10:00
|
Official
Introduction / Welcome Plenary
|
Regency
Ballroom
|
| |
Chair:
Stephen Lam |
|
|
08:15
- 08:25
|
Welcome
|
Stephen
Lam
|
|
08:25
- 08:45
|
Opening
Overview |
John
Cairns
Brian Schmidt
Bernie Bressler |
|
08:45
- 09:00
|
Establishment
of the IPA
|
Yoshihiro
Hayata
|
|
09:00
- 09:30
|
Keynote
Address
|
Stephen
Bown
|
|
09:30
- 10:00
|
AE
Profio Memorial Lecture
|
Bruce
Tromberg
|
| |
|
|
| 10:00
10:30 |
Refreshment
Break/Exhibits/Posters |
Regency
East
|
| 10:30
12:00 |
Plenary 2 |
Regency
Ballroom
|
| 10:30
11:00 |
Regulatory
Issues in Photodynamic Therapy |
Richard
Felten |
| 11:00
11:30 |
Clinical
Applications of PDT in Ophthalmology |
Neil
Bressler |
| 11:30
12:00 |
Gynecology |
Pius
Wyss |
| 12:00
13:30 |
Lunch
Break/Exhibits/Posters |
Regency
East
|
13:30
15:00
|
Concurrent
Symposia |
|
| Plaza
East |
Cardiovascular
(1 of 2)
Chairs: Kathryn Woodburn & Robert Grove
|
|
| 13:30
13:50 |
Intracoronary
Photopoint Therapy for Restenosis Antrin |
Ian
Leitch |
| 13:50
14:10 |
Photoangioplasty:
Initial Human Experience and Results of a Phase I Trial as Adjuvant
Therapy to Intracoronary Stent Implantation
Abstract
Chairs: Glenn M. Lamauraglia & York Hsiang
|
T.M.
Chou |
| 14:10
14:20 |
The
PhotoPoint Catheter Based System for the Treatment of Intimal Hyperplasia |
Steve
Rychnovsky |
| 14:20
14:30 |
Photodynamic
Inhibition of Intimal Hyperplasia in a Swine Arteriovenous Fistula
Model |
Beth
Allison |
| 14:30
14:40 |
Endovascular
Photodynamic Therapy with Aminolaevulinic Acid Inhibits Balloon Induced
Stenosis in Rat Illiac Arteries |
Edward
E.E. Gabeler |
| 14:40
14:50 |
Arterial-Type
Dependent Differences in the Aminolaevulininic-Acid- Induced Accumulation
of Protoporhyrin IX Determine the Timing For Photodynamic Therapy
|
Edward
E.E. Gabeler |
| 14:50
15:00 |
Tips
Plus PDT: A Pilot Study of Intimal Hyperplasia Prevention |
P.
Jack Hoopes
|
| Plaza
Centre |
Light
Sources and Delivery (1 of 2)
Chairs: Willem Star & Dan Doiron
|
|
| 13:30
13:45 |
Parametric
Study of Short Excitation Pulses on PDT Effects In Vitro with PAD-S31:
Measurements of Oxygen Consumption and Photobleaching |
Satoko
Kawauchi |
| 13:45
14:00 |
A
Novel Diode Laser System for Photodynamic Therapy |
Eva
Samsoee Andersen |
| 14:00
14:15 |
The
Effect Of Pulsed Laser In PDT In Vitro |
J.Y. Chen |
|
14:15 14:30 |
Dynamic Behaviour of Photosensitizers After Multiphoton Excitation |
David T. Cramb |
| 13:30
15:00 |
Concurrent
Symposia |
|
| Balmoral
Room |
Ophthalmology (1 of 2)
Chairs: Neil Bressler & Michael J. Potter |
|
| 13:30
13:55 |
Current
Benefits of Ocular Photodynamic Therapy with Verteporfin to Manage
Choroidal Neovascularization |
Neil
Bressler |
| 13:55
14:20 |
On-Going
Clinical Trials Evaluating Ocular Photodynamic Therapy with Verteporfin
to Manage Choroidal Neovascularization |
Michael
J. Potter |
| 14:20
14:35 |
Optimized
Light Dosimetry in Photodynamic Therapy of Choroidal Neovascularization |
Reginald
Birngruber |
| 14:35
14:50 |
Development of Verteporfin for the Treatment of Neovascular Age-Related
Macular Degeneration (AMD): Lessons Learned |
Julia
G. Levy |
| 14:50
15:05 |
Modulation of Photodynamic Therapy with Anti-Angiogenic Agents and
Other Strategies |
Reem
Z. Renno |
| Plaza
West |
Thoracic
Chairs: Tetsuya
Okunaka & Tom Sutedja |
|
| 13:30
13:45 |
The
significance of fluorescence imaging in lung cancer. Autofluorescence
Versus Added Photosensitizer |
Tetsuya
Okunaka |
| 13:45
14:00 |
PDT with Nd-YAG Laser Therapy for Lung Cancer |
J.S.
McLaughan Jr. |
| 14:00
14:10 |
Phase
II Clinical Trial of PDT Using ME2906 and Diode Laser in the Treatment
of Central Type Early Stage Lung Cancer in Japan |
Kinya
Furukawa |
| 14:10
14:20 |
Intrathoracic
Photodynamic Therapy on Pleural-Based Mesothelioma in Rats |
Thorsten
Krueger |
| 14:20
14:30 |
10
Years Experience In Endoscopic Photodynamic Therapy (PDT) For Inoperable
Cancer Of The Aero-Digestive Tract: The Lesson Learnt |
Keyvan
Moghissi |
| 14:30
14:40 |
Has
Bronchoscopic Photodynamic Therapy (PDT) Any Place In Bronchopulmonary
Cancer Treatment? |
Keyvan
Moghissi |
| 14:40
14:50 |
Photodynamic Therapy: An Integral Component of Multi-Modality Treatment
for Bronchogenic Carcinoma |
Patrick
Ross |
| 14:50
15:00 |
Clinical
Experience with Safe 1000 Pentax Autofluorescence Bronchoscopy system
in Early and Invasive Lung Cancer (First year experience) |
Lamberto
Toniolo |
| 15:00
15:10 |
Autofluorescence-Guided
Bronchoscopic Biopsy for Localization of Pre-Malignant Lesions and
Cancer Foci within Bronchi |
Mariusz
Adamek |
| Regency
Ballroom |
Mechanisms
of Action (1 of 3)
Chairs: Barbara
W. Henderson & Nancy L. Oleinick |
|
| 13:30
13:50 |
Tissue
Responses to PDT |
Barbara
W. Henderson |
| 13:50
14:10 |
Mechanisms
of PDT Cell Killing |
Nancy
L. Oleinick |
| 14:10
14:22 |
A
Mathematical Evaluation of Dose Dependent PpIX Fluorescence Kinetics
In Vivo |
HJCM
Sterenborg |
| 14:22
14:34 |
Tissue
Temperature and Po2 Measurements
Using Planar Optical Sensors In Vivo |
Christoph
Abels |
| 14:34
14:46 |
Fas
(CD95) Dependent Mechanisms of Cell Death Following DNA Damage in
Human Nasopharyngeal Carcinoma Cells Using Hypocrellins |
S.M.
Ali Renato |
| 14:46
15:00 |
Analyses of Cellular Activity After PDT with AIPcS4 |
Amaro
Zβngaro |
| 15:00
15:30 |
Afternoon
Break/Exhibits/Posters
|
Regency
East
|
| 15:30
17:00 |
Concurrent
Symposia |
|
| Balmoral
Room |
Ophthalmology
(2 of 2)
Chair: Michael J. Potter |
|
| 15:30
15:45 |
2.
Generation of PDT-Lasers for the Treatment of Wet AMD |
Stefan
Spaniol |
| 15:45
16:00 |
In Vitro Photodynamic Effects of ATX-S10(Na) and Mode of Cell Death
on Vascular Endothelial Cells |
Yuko
Gohto |
| 16:00
16:15 |
Subcellular
Localization of Three Photosensitizers in Vascular Endothelial Cells
|
Akira
Obana |
| 16:15
16:30 |
Evaluation
of New Photosensitizer MV6401 In a Series of Ophthalmic Neovascularization
Models |
Wendy
J. Snyder |
| 16:30
16:45 |
Improvements in Laser Technology for Ocular Photodynamic Therapy with
Verteporfin |
Hubert
van den Bergh |
| Plaza
East |
ENT
Chairs: Phillipe Monnier & Colin Hopper |
|
| 15:30
15:40 |
Experimental
Animal Study of 5-Aminolevulinic Acid Induced Photodynamic Therapy
of Oral Cancer |
B.
Rings |
| 15:40
15:50 |
Clinical
Effects of Treating Recurrent Laryngeal Papillomatosis With Photodynamic
Therapy Using m-THPC (FOSCAN) |
Allan
L. Abramson |
| 15:50
16:00 |
Combined
Fluorescence Diagnosis (Autofluorescence and 5-ALA Induced PPIX-Fluorescence)
for the Detection and Demarcation of Oral Cancer |
Christian
Betz |
| 16:00
16:10 |
The
Use of Intravenous 5-Aminolaevulinic Acid in Photodynamic Therapy
and in Fluorescence Imaging for Head and Neck Cancer and Precancer |
Hiroaki
Nakanishi |
| 16:10
16:20 |
Targeting the Treatment Volume in Head and Neck Cancer |
Graham
D. Putnam |
| 16:20
16:30 |
Raman
Spectroscopy as a Means of Optical Biopsy in Normal and Cancerous
Tissue of the Nasopharynx |
David
Lau |
| 16:30
16:40 |
Photofrin-Mediated
Photodynamic Therapy for Treatment of Early Stage Oral Cavity and
Laryngeal Malignancies |
Vanessa
Gayl Schweitzer |
| 16:40
16:50 |
Performance
Characteristics of Laser-Induced Fluorescence Endoscope in Detection
of Head and Neck Cancers |
Vipa
Boonkitticharoen |
| 16:50
17:00 |
Fluorescence-Guided
Biopsy in the Diagnosis of an Unknown Primary Cancer in Patients with
Metastatic Cervical Lymph Nodes |
Boonchu
Kulapaditharom |
| 17:00
17:10 |
Clinical
Response to Photodynamic Therapy of Premalignant Lesions and Advanced
Head and Neck Carcinomas |
Maciej
Misiolek |
| Regency
Ballroom |
Advances
in PDT
Chairs: Heinrich
Walt & Thierry Patrice |
|
| 15:30
15:50 |
Oral
Aminolevulinic Acid for Systemic Breast Tumor Diagnosis |
Heinrich
Walt |
| 15:50
16:10 |
Why
is ALA-PDT Tumor-Selective? |
Li-Wei
Ma |
| 16:10
16:20 |
Quantification
and Specification of Postischemic Reperfusion Injury of Human Allogenic
Kidney and Pancreas Transplants |
Helmut
P. Arbogast |
| 16:20
16:40 |
Fluerescence
Diagnosis with ALA-Induced Porphyrins (FDAP) in Dermatology |
Clemens
Fritsch |
| 16:40
17:00 |
Optimizing
the Esters of ALA in Vitro and in Organ Culture |
Hubert
van den Bergh |
| 17:00
17:12 |
Anti-Tumor
Vascular Effects of Photodynamic Therapy MV6401 |
Dennis
Dolmans |
| 15:30
17:00 |
Concurrent
Symposia |
|
| Plaza
West |
Photosensitizers
(1 of 3)
Chairs: Stan
Brown & David Kessel |
|
| 15:30
15:50 |
Thiazine
Photosensitizers |
Stan
Brown |
| 15:50
16:10 |
Photosensitizers - A Review of the Options |
David
Kessel |
| 16:10
16:20 |
Clinical
Application of a New Surgical Strategy Using Photodynamic Therapy
With Acridine Orange to Malignant Soft Tissue Tumors |
Katsuyuki
Kusuzaki |
| 16:20
16:30 |
A
Photodynamic Pathway to Apoptosis Induced by Polycyclic Aromatic Ketone
(Hypericin) in Human Mucosal Cell Lines: Possible Relevance to Photodynamic
Therapy |
S.M.
Ali |
| 16:30
16:40 |
In Vitro and In Vivo Behaviour of BPD Related Compounds |
Ron
Boch |
| 16:40
16:50 |
Hydroxy
Diphenyl Chlorins and Bacteriochlorins Versatile PDT Photosensitizers
|
R.W.
Boyle |
| 16:50
17:00 |
Enhanced
Phototoxicity of Cationic Sulfonamide Derivatives of Benzochlorin
and Porphycene With Nasopharyngeal Cancer Cells |
C.K.
Chang |
| Plaza
Centre |
Light
Sources and Delivery (2 of 2)
Chairs: Tom
Mang & David Cramb |
|
| 15:30
15:42 |
Model
Calculation on the Efficiency of PDT by Pulsed Laser Application |
Hans-Jochen
Foth |
| 15:42
15:54 |
Photodynamic
Therapy Using Lowly Sinusoidal Modulated Thermal Red Light |
Heinrich
Kolbabek |
| 15:54
16:06 |
Interstitial
Photodynamic Therapy Results from Treatments and Dosimetry Measurements
|
Stefan
Andersson-Engel |
| 16:06
16:18 |
Novel
System for Integrated Interstitial Photodynamic Therapy, Dosimetry
Measurements and Prediction of Treatment Outcome |
Marcelo
Soto Thompson |
| 16:18
16:30 |
Reinforcement
of Therapeutic Efficacies for Malignant Tumors Using Low Power Laser
Preirradiation Preliminary Report |
Hideaki Shimatani |
| 16:30
16:42 |
Local
NPE6 Sensitized PDT for Inhibiting Intimal Hyperplasia in Experimental
Balloon Injured Arteries |
Tsuneyuki
Nagae |
| 19:00 |
Welcome
Reception |
Vancouver
Aquarium |
| |
Buses
depart from Melville Street entrance 18:45 19:10. |
|
